Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Phase Ib data of synthetic cis-retinoid therapy for patients with genetic retinal defects

Sep. 19, 2014

NicOx obtains antiviral eye drop program from Marinomed

Sep. 17, 2014

Otonomy releases phase III data for AuriPro in middle ear effusion

July 10, 2014

Autifony Therapeutics awarded grant to support phase IIa study of AUT-00063 for tinnitus

June 10, 2014

Close-field electroporation gene delivery for damaged cochlear hair cells regeneration

May 29, 2014

Novartis plans phase I/II study of CGF-166

May 15, 2014

Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing

May 2, 2014

Oricula Therapeutics secures intellectual property and funding to prevent hearing loss

April 10, 2014

Amarantus acquires option to license intellectual property for MANF and CDNF

March 10, 2014

Auris Medical enrolls first patient in European study of AM-101 in peripheral tinnitus

Feb. 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...